Revive Therapeutics Ltd. (RVV)

Revive Therapeutics Logo White

Revive Therapeutics

CSE: RVV | OTC: RVVTF 

Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly.

Revive Therapeutics
$0.4450
-3.26%
$0.0200

Latest News

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

August 17, 2021

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

August 10, 2021

Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

June 17, 2021

Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip

May 17, 2021

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury

April 27, 2021

Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application

April 22, 2021

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.